Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us prof. dr. S. (Sandy) Schmidt

Research interests

The research of Prof. Dr. S. Schmidt exploits the powerful reactivity and selectivity of enzymes from secondary metabolite pathways for the production of natural products and their analogs for pharmaceutical applications. One of the main areas of interest is the identification, characterization and the engineering of Rieske non-heme iron oxygenases for their application in biocatalytic reactions towards pharmaceuticals and/or precursors thereof. Along this line, the outstanding reactivities of these biocatalysts are exploited in synthetic metabolic pathways and (chemo)enzymatic cascade reactions for the production of complex compounds from simple precursors. The Schmidt group is thereby using state-of-the-art synthetic biology tools for the design and assembly of artificial metabolic pathways, and is developing new methodologies for the genetic engineering of several chassis strains. Finally, the Schmidt group aims at the development of new concepts for electron transfer pathways in microorganisms, and is developing concepts to optimize electron transfer chains in multi-component oxidoreductases. By expanding our knowledge on the parameters determining efficient electron transfer and thus catalysis, it is expected that this will increase the broad applicability of multi-component oxidoreductases relying on complex electron transfer mechanisms.

Publications

Characterization and Crystal Structure Elucidation of the L-Homoserine O-Succinyltransferase MetXS from Cupriavidus necator H16

Crystal Structure and Conformational Dynamics of N─N Bond-Forming Piperazate Synthase

Decoding and Reprogramming Redox Partner Specificity in Rieske Oxygenases for Enhanced Catalytic Activity

Enzymatic synthesis of bioactive quinolones and (thio)coumarins by fungal type III polyketide synthases

Nitroreductase-triggered indazole formation

Protein engineering: Status report

Access to nitrogen-nitrogen bond-containing heterocycles through substrate promiscuity of piperazate synthases

Access to Nitrogen − nitrogen Bond-Containing Heterocycles Through Substrate Promiscuity of Piperazate Synthases

Chemoenzymatic synthesis

Cupriavidus necator as a model organism for CO2-based biotechnology

Press/media

Neue Wirkstoffe gegen Bakterien und Pilze?

Revolution im Kampf gegen Keime: Innovative Wirkstoffe aus Mikroben

Bodembacterie maakt eiwitten en geneesmiddelen uit kooldioxide

Herausgeber des RÖMPP - Thieme Chemistry - Georg Thieme Verlag

RUG onderzoeker ontdekt ‘superbacterie’ die schadelijk CO2 omzet in geneesmiddelen

In Groningen gemanipuleerde bacterie ‘maakt kaas en medicijnen van CO2’

Soil bacteria produce proteins from carbon dioxide

Sandy Schmidt awarded ERC Starting Grant

Sustainable Development Goals

SDG 3 - Good Health and Well-beingSDG 7 - Affordable and Clean EnergySDG 9 - Industry, Innovation, and InfrastructureSDG 12 - Responsible Consumption and ProductionSDG 13 - Climate ActionSDG 15 - Life on Land

More information about the Sustainable Development Goals.